CLINICAL DISEASE ACTIVITY INFLUENCES THE THERAPEUTIC EFFICACY OF THE TOLL LIKE RECEPTOR-9 AGONIST COBITOLIMOD IN PATIENTS WITH MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS

Raja Atreya  1     Laurent Peyrin-Biroulet  2     Walter Reinisch  3     Franco Scaldaferri  4     Charlotte Admyre     Thomas Knittel     Jan Kowalski     Markus F. Neurath     Christopher John Hawkey    
1 University Erlangen-Nuremberg, Medical Department 1, Erlangen, Germany
2 Nancy University Hospital, Department of Gastroenterology, Vandoeuvre les Nancy, France
3 Medizin. Universität Wien Abt. für Innere Medizin III, Dep.of Internal Medicine IV, Division of Gastroenterology and Hepatology, Wien, Austria
4 Catholic University of Rome Dept.

Conference
UEG Week 2016

Citation
United European Gastroenterology Journal; 2016: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at office@ueg.eu

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing